BACKGROUND: Central blood pressure (BP) is a promising marker to identify subjects with higher cardiovascular risk than expected by traditional risk factors. Significant results have been obtained in populations with high cardiovascular risk, but little is known about low-cardiovascular-risk patients, although the differences between central and peripheral BP (amplification) are usually greater in this population. The study aim was to evaluate central BP over 24 hours for cardiovascular event prediction in hypertensive subjects with low cardiovascular risk. METHODS AND RESULTS: Peripheral and central BPs were recorded during clinical visits and over 24 hours in hypertensive patients with low cardiovascular risk (Systematic Coronary Risk Eva...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Most of large controlled randomized trials have not revealed superiority of "new" over "old" anti hy...
ObjectivesThis study was designed to facilitate clinical use of central pulse pressure (PP). We soug...
ObjectivesThis study sought to derive and validate outcome-driven thresholds of central blood pressu...
AIM: The aim of the present study was to evaluate the association of central blood pressure (BP) wit...
Although the differences between central and peripheral BP (blood pressure) have been known for deca...
Objective: The VASOTENS international, multicenter, observational, non-randomized, prospective study...
[[abstract]]AbstractObjectives This study sought to derive and validate outcome-driven thresholds of...
Background Central blood pressure (BP) predicts mortality independent of office brachial BP. Whether...
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular en...
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular en...
Background Central blood pressure (BP) predicts mortality independent of office brachial BP. Whether...
Abstract High blood pressure (BP) confers cardiovascular risk. However, the clinical value of centra...
OBJECTIVE: We assessed the relationship between pulse pressure and intermediate cardiovascular pheno...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Most of large controlled randomized trials have not revealed superiority of "new" over "old" anti hy...
ObjectivesThis study was designed to facilitate clinical use of central pulse pressure (PP). We soug...
ObjectivesThis study sought to derive and validate outcome-driven thresholds of central blood pressu...
AIM: The aim of the present study was to evaluate the association of central blood pressure (BP) wit...
Although the differences between central and peripheral BP (blood pressure) have been known for deca...
Objective: The VASOTENS international, multicenter, observational, non-randomized, prospective study...
[[abstract]]AbstractObjectives This study sought to derive and validate outcome-driven thresholds of...
Background Central blood pressure (BP) predicts mortality independent of office brachial BP. Whether...
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular en...
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular en...
Background Central blood pressure (BP) predicts mortality independent of office brachial BP. Whether...
Abstract High blood pressure (BP) confers cardiovascular risk. However, the clinical value of centra...
OBJECTIVE: We assessed the relationship between pulse pressure and intermediate cardiovascular pheno...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Background: High blood pressure (BP) is the most common modifiable cause of death from cardiovascula...
Most of large controlled randomized trials have not revealed superiority of "new" over "old" anti hy...